PharmaPeek Market Reports


There is data, and then there is intelligence.

While many industry reports focus on amassing and analyzing publicly available data, PharmaPeek goes beyond the numbers, press releases and quarterly reports. PharmaPeek market reports are based on interviews with key opinion leaders, subject matter experts, key executives and end users. While other market reports claim to contain primary research, only PharmaPeek includes the actual transcripts from primary interviews.*

PharmaPeek Therapeutic Market Reports address the full therapeutic/device pipeline, from development and clinical trials to marketed products, generic threats and biosimilars. Our reports provide insight directly from the industry stakeholders and thought leaders.

Each report is based on numerous primary interviews. The insights gathered from these interviews are analyzed to produce a clear and succinct picture of the therapeutic/device landscape.

*Transcripts are not applicable to every PharmaPeek report. Please refer to the Table of Contents under any report details page for more information.



Current Reports

standard report icon

Comprehensive Landscape and Expert Opinions on the Treatment of Multiple Sclerosis $2500

PUBLICATION DATE: Jan 2012

This report examines the current opinions of experts in the field concerning MS treatment options. The report also reviews potential drug treatments in Phase III clinical trials. Combining key opinion leader input with a drug development pipeline (including key market drivers and challenges), the report provides readers with a comprehensive MS therapeutic landscape.

super report icon

US Targeted Therapeutics Comprehensive Analysis:
Detailed Pipeline Analysis & Market Forecast 2010-2013 $3000

PUBLICATION DATE: Aug 2010

The US Targeted Therapeutics Comprehensive Analysis: Detailed Pipeline Analysis & Market Forecast report provides valuable insights and access to the competitive information influencing the direction of the targeted therapies market from 2010 -2013. This report is saturated with information highlighting the individual products used in each MOA in a detailed pipeline analysis. The report is very thorough and goes one step beyond our Targeted Therapeutics Market Analysis.

standard report icon

US Targeted Therapeutics Market Analysis:
Detailed Market Forecast 2010-2013 $2000

PUBLICATION DATE: Aug 2010

The Targeted Therapeutics Market Analysis report provides valuable insights and access to the competitive information influencing the direction of the targeted therapies market from 2010-2013. PharmaPeek has divided the report by therapy class for quick reference and included revenue analysis along with a very detailed product analysis. This report is saturated with information highlighting the targeted therapy market.

standard report icon

US Type 2 Diabetes:
Market Forecast & Pipeline Analysis 2010-2013 $2500

PUBLICATION DATE: Oct 2010

PharmaPeek's US Type 2 Diabetes Market Report provides valuable insight and access to the competitive information necessary to make decisions regarding the direction of the market from 2010-2013. Our report features analyzed information gathered from pharmaceutical, payer, and key opinion leader interviews.This report reveals what changes lay ahead for the diabetes market in the US, and evaluates current drugs along with projections on drugs poised to influence the future market.

standard report icon

Analysis of US Biogenerics:
A Managed Care Perspective $2000

PUBLICATION DATE: Jul 2010 (updated)

Along with access to the clearly organized competitive information, PharmaPeek's Biogenerics Analysis Report provides valuable insights regarding the direction of the biogenerics market from 2009-2013. This report presents both various limitations to the growth of biogenerics, as well as the effect that they will have on the growth of current biologics. The information provided focuses on the opinions of payers (including managed care, employers, and patients). Featured data was gathered from pharmaceutical, payer, and key opinion leader interviews. This report was first published in September of 2009, but later updated in July of 2010.

standard report icon

US Renal Cell Carcinoma:
Competitive Market Analysis and Forecast 2010-2013 $1500

PUBLICATION DATE: Aug 2010

With a growth rate of 5% per year in market size, Renal Cell Carcinoma treatments are likely to have many changes in market share throughout the forecast period of 2010-2013. Although few new players are likely to enter the market, market share will vary with an increased diagnosis rate as well as treatment effectiveness measures. PharmaPeek’s report provides a close examination of the market in its entirety.

standard report icon

Global Colorectal Cancer:
Market and Pipeline Analysis 2010-2013 $2500

PUBLICATION DATE: Oct 2010

The Market and Pipeline Analysis report focused on Global Colorectal Cancer provides a look at the evolved therapies and drugs currently being used in treatments, as well as those in development. As one of the most common forms of cancer, the market for this area is rapidly growing and changing. Global market potential is an important component to this report, as variances by countries are highlighted.

light report icon

Bladder Cancer:
Strategic Analysis of the Therapeutics Market FREE

PUBLICATION DATE: Sep 2010 (updated)

In this report, PharmaPeek presents a concise analysis of the global bladder cancer therapeutics market. This analysis includes challenges, factors driving growth, and revenue forecasts from 2010-2013. Competitive opportunities are identified, as well as novel strategies to exploit these opportunities and overcome industry challenges.